StockData
Calidi Biotherapeutics, Inc. logo

Calidi Biotherapeutics, Inc. (CLDI) stock

CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$0.62−0.03 (-5.08%)

Close on Nov 13, 2026Market cap $1.61MP/E –Yield –

Calidi Biotherapeutics statistics

59 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 26, 2027 (estimated, during market hours)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$1.61M
$272.32M
Enterprise Value
-$1.67M
$146.23M
PB Ratio
0.99
2.00
P/TBV Ratio
0.99
2.22

Share statisticsIndustry

Shares Change (YoY)
622.2%
10.8%
Shares Change (QoQ)
38.5%
0.50%
Float
1M
49M
Shares Held by Insiders
58.4%
11.7%

Short sellingIndustry

Short Interest
135,691
–
Short Interest Change
-17.4%
-0.80%
Days to Cover
2.48
5.15

Stock price statisticsIndustry

52-Week High
$24.96
–
52-Week Low
$0.62
–
20-Day Moving Average
$0.69
–
50-Day Moving Average
$0.94
–
200-Day Moving Average
$3.65
–
Average True Range (14)
$0.07
–
Price Change (1 Week)
-11.2%
-1.15%
Price Change (1 Month)
-28.5%
-4.87%
Price Change (3 Months)
-54.3%
-21.0%
Price Change (6 Months)
-79.1%
-20.6%
Price Change (YTD)
-96.7%
-23.6%
Price Change (1 Year)
-97.4%
-22.4%
Price Change (3 Years)
-100.0%
-29.5%
Price Change (5 Years)
-100.0%
-77.9%
Average Volume (10 Days)
35,320
–
Average Volume (20 Days)
46,015
–
Average Volume (90 Days)
197,237
–
Relative Volume
0.14
0.70
Relative Strength Index (14)
32.3
43.4
Volatility (1 Year)
93.9%
80.1%
Beta (5 Years)
0.50
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-373.6%
-49.9%
Return on Assets (ROA)
-163.4%
-40.6%
Return on Capital Employed (ROCE)
-954.3%
-37.9%

Financial positionIndustry

Current Ratio
1.27
3.30
Quick Ratio
1.06
2.39
Debt / Equity
0.41
0.49
Interest Coverage
-252.18
-6.35

EfficiencyIndustry

WACC
7.74%
10.2%

Income statement (TTM)Industry

Operating Income
-$17.15M
-$21.37M
Pretax Income
-$15.96M
-$12.95M
Net Income
-$15.97M
-$22.35M
EBITDA
-$15.44M
-$17.21M

Balance sheetIndustry

Total Debt
$668.00K
$116.91M
Net Cash (Debt)
$3.28M
$17.76M
Net Cash Per Share
$1.27
$0.80
Equity (Book Value)
$1.63M
$53.89M
Book Value Per Share
$0.63
$1.50
Tangible Book Value
$1.63M
$27.13M
Working Capital
$1.01M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$15.85M
-$12.38M

Dividends and yieldsIndustry

Earnings Yield
-993.7%
-21.8%

Taxes and interestIndustry

Interest Expense
$68.00K
$2.90M
Income Tax
$16.00K
$73.00K

Scores and fair valueIndustry

Altman Z-Score
-48.70
0.23
Piotroski F-Score
3
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodCLDIS&P 500DifferenceCLDI per yearS&P 500 per year
1 month-30.9%-3.0%−27.9 pts
3 months-59.6%-2.8%−56.8 pts
Year to date-96.7%+11.5%−108.2 pts
1 year-97.4%+13.5%−110.9 pts
3 years-100.0%+77.7%−177.7 pts-94.7%+21.1%
5 years-100.0%+72.6%−172.6 pts-87.3%+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M CLDI shares were sold short on Oct 30, 2026, down 17.4% from the previous report. At recent volumes it would take 2.5 days to buy them back. Over the last 20 sessions, 25.7% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026135,691-17.4%54,7542.5
Oct 15, 2026164,295-29.6%39,2274.2
Sep 30, 2026233,287+2.4%380,1011.0
Sep 15, 2026227,775-1.4%36,5726.2
Aug 31, 2026231,117-26.2%98,1002.4
Aug 14, 2026313,261+35.4%201,5761.6
Jul 31, 2026231,318-93.2%665,8881.0
Jul 15, 20263,421,439-20.0%2,133,8661.6
Jun 30, 20264,276,018+251.3%6,265,1611.0
Jun 15, 20261,217,102+63.6%4,877,8891.0
May 29, 2026743,922+10.9%2,295,4261.0
May 15, 2026670,614-77.9%2,410,7481.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?